rs201681071
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The NM_014332.3(SMPX):c.182A>G(p.Lys61Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,207,834 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014332.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPX | NM_014332.3 | c.182A>G | p.Lys61Arg | missense_variant | 4/5 | ENST00000379494.4 | |
SMPX | XM_047441939.1 | c.182A>G | p.Lys61Arg | missense_variant | 4/7 | ||
SMPX | XM_047441940.1 | c.182A>G | p.Lys61Arg | missense_variant | 4/5 | ||
SMPX | NR_045617.2 | n.369A>G | non_coding_transcript_exon_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPX | ENST00000379494.4 | c.182A>G | p.Lys61Arg | missense_variant | 4/5 | 1 | NM_014332.3 | P1 | |
SMPX | ENST00000646008.1 | c.182A>G | p.Lys61Arg | missense_variant | 4/5 | P1 | |||
SMPX | ENST00000494525.1 | c.182A>G | p.Lys61Arg | missense_variant, NMD_transcript_variant | 4/6 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000178 AC: 2AN: 112345Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34495
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 183294Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67784
GnomAD4 exome AF: 0.0000201 AC: 22AN: 1095489Hom.: 0 Cov.: 29 AF XY: 0.0000139 AC XY: 5AN XY: 360923
GnomAD4 genome ? AF: 0.0000178 AC: 2AN: 112345Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34495
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 23, 2016 | The p.Lys61Arg variant in SMPX has not been previously reported in individuals w ith hearing loss. This variant has been identified in 1/47913 European chromosom es by the Exome Aggregation Consortium, and the variant was reportedly in the he mizygous state (ExAC, http://exac.broadinstitute.org; dbSNP rs201681071). Comput ational prediction tools and conservation analyses suggest that the p.Lys61Arg v ariant may not impact the protein, though this information is not predictive eno ugh to rule out pathogenicity. In summary, the clinical significance of the p.Ly s61Arg variant is uncertain. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 19, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 229261). This variant has not been reported in the literature in individuals affected with SMPX-related conditions. This variant is present in population databases (rs201681071, ExAC 0.002%). This sequence change replaces lysine with arginine at codon 61 of the SMPX protein (p.Lys61Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at